NEW BIOLOGICALLY ACTIVE COMPOSITION, METHOD FOR ITS PREPARATION AND APPLICATION
The pharmaceutical compositions are used for the treatmentand easying the symptoms of vulvitis and volvovaginitis. Theycontain in wt.%: 0.05-0.5 folic acid, 0.25-2.5 panthenol and/or0.15-1.5 alantoin, 0.75-7.5 protein hydrolysate or caseinhydrolysate, 3.0-15.0 lactose or dextrose, 0.25-2.5 lactic ac...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | bul ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | OLAH, GABORNE TOKOS, EDIT HANGAY, GYOERGY MEHESZ, ERNO VAMOS, GYOERGY MEHESZ, ERNONE |
description | The pharmaceutical compositions are used for the treatmentand easying the symptoms of vulvitis and volvovaginitis. Theycontain in wt.%: 0.05-0.5 folic acid, 0.25-2.5 panthenol and/or0.15-1.5 alantoin, 0.75-7.5 protein hydrolysate or caseinhydrolysate, 3.0-15.0 lactose or dextrose, 0.25-2.5 lactic acid,0.25-2.5 magnesium sulphate and 0.75-7.5 sodium chloride orammonium chloride and are formulated as suppositors, ointments,solutions and sprays. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BG62036BB1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BG62036BB1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BG62036BB13</originalsourceid><addsrcrecordid>eNrjZPD3cw1XcPL09_F393R29PGJVHB0DvEMc1Vw9vcN8A_2DPH099NR8HUN8fB3UXDzD1LwDAlWCAhyDXAMcgTJKTj6uSg4BgT4AHWD-DwMrGmJOcWpvFCam0HezTXE2UM3tSA_PrW4IDE5NS-1JN7J3czIwNjMycnQmLAKAJuhLhA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NEW BIOLOGICALLY ACTIVE COMPOSITION, METHOD FOR ITS PREPARATION AND APPLICATION</title><source>esp@cenet</source><creator>OLAH, GABORNE ; TOKOS, EDIT ; HANGAY, GYOERGY ; MEHESZ, ERNO ; VAMOS, GYOERGY ; MEHESZ, ERNONE</creator><creatorcontrib>OLAH, GABORNE ; TOKOS, EDIT ; HANGAY, GYOERGY ; MEHESZ, ERNO ; VAMOS, GYOERGY ; MEHESZ, ERNONE</creatorcontrib><description>The pharmaceutical compositions are used for the treatmentand easying the symptoms of vulvitis and volvovaginitis. Theycontain in wt.%: 0.05-0.5 folic acid, 0.25-2.5 panthenol and/or0.15-1.5 alantoin, 0.75-7.5 protein hydrolysate or caseinhydrolysate, 3.0-15.0 lactose or dextrose, 0.25-2.5 lactic acid,0.25-2.5 magnesium sulphate and 0.75-7.5 sodium chloride orammonium chloride and are formulated as suppositors, ointments,solutions and sprays.</description><edition>6</edition><language>bul ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990129&DB=EPODOC&CC=BG&NR=62036B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990129&DB=EPODOC&CC=BG&NR=62036B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OLAH, GABORNE</creatorcontrib><creatorcontrib>TOKOS, EDIT</creatorcontrib><creatorcontrib>HANGAY, GYOERGY</creatorcontrib><creatorcontrib>MEHESZ, ERNO</creatorcontrib><creatorcontrib>VAMOS, GYOERGY</creatorcontrib><creatorcontrib>MEHESZ, ERNONE</creatorcontrib><title>NEW BIOLOGICALLY ACTIVE COMPOSITION, METHOD FOR ITS PREPARATION AND APPLICATION</title><description>The pharmaceutical compositions are used for the treatmentand easying the symptoms of vulvitis and volvovaginitis. Theycontain in wt.%: 0.05-0.5 folic acid, 0.25-2.5 panthenol and/or0.15-1.5 alantoin, 0.75-7.5 protein hydrolysate or caseinhydrolysate, 3.0-15.0 lactose or dextrose, 0.25-2.5 lactic acid,0.25-2.5 magnesium sulphate and 0.75-7.5 sodium chloride orammonium chloride and are formulated as suppositors, ointments,solutions and sprays.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPD3cw1XcPL09_F393R29PGJVHB0DvEMc1Vw9vcN8A_2DPH099NR8HUN8fB3UXDzD1LwDAlWCAhyDXAMcgTJKTj6uSg4BgT4AHWD-DwMrGmJOcWpvFCam0HezTXE2UM3tSA_PrW4IDE5NS-1JN7J3czIwNjMycnQmLAKAJuhLhA</recordid><startdate>19990129</startdate><enddate>19990129</enddate><creator>OLAH, GABORNE</creator><creator>TOKOS, EDIT</creator><creator>HANGAY, GYOERGY</creator><creator>MEHESZ, ERNO</creator><creator>VAMOS, GYOERGY</creator><creator>MEHESZ, ERNONE</creator><scope>EVB</scope></search><sort><creationdate>19990129</creationdate><title>NEW BIOLOGICALLY ACTIVE COMPOSITION, METHOD FOR ITS PREPARATION AND APPLICATION</title><author>OLAH, GABORNE ; TOKOS, EDIT ; HANGAY, GYOERGY ; MEHESZ, ERNO ; VAMOS, GYOERGY ; MEHESZ, ERNONE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BG62036BB13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>bul ; eng</language><creationdate>1999</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>OLAH, GABORNE</creatorcontrib><creatorcontrib>TOKOS, EDIT</creatorcontrib><creatorcontrib>HANGAY, GYOERGY</creatorcontrib><creatorcontrib>MEHESZ, ERNO</creatorcontrib><creatorcontrib>VAMOS, GYOERGY</creatorcontrib><creatorcontrib>MEHESZ, ERNONE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OLAH, GABORNE</au><au>TOKOS, EDIT</au><au>HANGAY, GYOERGY</au><au>MEHESZ, ERNO</au><au>VAMOS, GYOERGY</au><au>MEHESZ, ERNONE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NEW BIOLOGICALLY ACTIVE COMPOSITION, METHOD FOR ITS PREPARATION AND APPLICATION</title><date>1999-01-29</date><risdate>1999</risdate><abstract>The pharmaceutical compositions are used for the treatmentand easying the symptoms of vulvitis and volvovaginitis. Theycontain in wt.%: 0.05-0.5 folic acid, 0.25-2.5 panthenol and/or0.15-1.5 alantoin, 0.75-7.5 protein hydrolysate or caseinhydrolysate, 3.0-15.0 lactose or dextrose, 0.25-2.5 lactic acid,0.25-2.5 magnesium sulphate and 0.75-7.5 sodium chloride orammonium chloride and are formulated as suppositors, ointments,solutions and sprays.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | bul ; eng |
recordid | cdi_epo_espacenet_BG62036BB1 |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
title | NEW BIOLOGICALLY ACTIVE COMPOSITION, METHOD FOR ITS PREPARATION AND APPLICATION |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T09%3A12%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OLAH,%20GABORNE&rft.date=1999-01-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBG62036BB1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |